新形成的血小板中的糖蛋白VI信号缺陷在压力血栓形成中产生
Stephanie R Hyslop1, Jason Corbin2, Pradnya Gangatirkar2
1The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
新产生的血小板在压力血栓形成过程中可能会在糖蛋白VI (GPVI) 信号中出现暂时的缺陷. 这种短暂的GPVI信号缺陷在多种血小板缺陷模型中观察到,这表明年轻的血小板需要时间在循环中才能完全功能.
科学领域:
- 血液学 血液学 血液学
- 血小板生物学 血小板生物学
- 免疫学 免疫学 免疫学
背景情况:
- 新产生的血小板通常被认为比旧的更具功能.
- 最近的研究表明,在免疫媒介性血小板缺陷后,小鼠血小板中存在过渡性葡萄糖蛋白 (GP) VI信号缺陷.
研究的目的:
- 调查其他压力血栓形成模型是否也会产生具有功能缺陷的血小板.
- 评估年轻血小板的功能完整性在各种血小板缺血条件下.
主要方法:
- 评估血小板功能使用光传输聚合计和流动细胞计.
- 研究了血小板缺血的遗传和疾病模型,包括化疗诱导的模型.
- 分析了血小板脱粒,整合素激活,聚合和Syk酸化.
主要成果:
- 来自多重血小板衰竭模型的血小板对GPVI激动剂发素的反应减弱,但对血小板蛋白没有反应.
- 减少了血小板聚合和GPVI下游的Syk酸化被观察到对的反应.
- 在卡博普拉丁诱导或免疫介导的血小板缺陷的复苏期间,观察到过渡性GPVI缺陷.
结论:
- 血小板GPVI信号传递中的功能缺陷存在于多重血小板缺血的模型中,其中增加了年轻血小板.
- 这些发现表明,GPVI受体需要循环时间才能在应激血栓形成过程中达到充分功能.
更多相关视频
08:30Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Intracellular Signaling Affects Focal Adhesions
Some...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
